XML 19 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 91.4 $ 80.2
Adjustments to reconcile net income to net cash provided by operating activities:    
Share-based compensation expense 51.8 46.0
Depreciation, amortization, and accretion 47.0 47.5
Restructuring and other charges 0.0 1.4
Deferred income taxes 21.1 11.3
Loss (gain) on investments, net 5.4 (0.6)
Excess tax benefits from share-based compensation 0.0 (1.7)
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable, net (3.2) 54.2
Prepaid expenses and other assets (59.6) (21.8)
Accounts payable 69.8 (7.8)
Accrued compensation (89.3) (54.1)
Income taxes payable (24.2) 14.1
Other accrued liabilities (29.8) (48.4)
Deferred revenue 92.0 99.0
Net cash provided by operating activities 172.4 219.3
Cash flows from investing activities:    
Purchases of property and equipment (49.3) (44.2)
Purchases of available-for-sale investments (360.7) (398.8)
Proceeds from sales of available-for-sale investments 286.2 169.5
Proceeds from maturities of available-for-sale investments 79.6 57.3
Purchases of trading investments (2.5) (1.9)
Purchases of privately-held investments (10.5) (3.2)
Net cash used in investing activities (57.2) (221.3)
Cash flows from financing activities:    
Proceeds from issuance of common stock 32.0 31.8
Purchases and retirement of common stock (83.4) (402.4)
Issuance of long-term debt, net 494.0 594.6
Repayment of long-term debt (300.0) 0.0
Payment for capital lease obligation 0.0 0.4
Excess tax benefits from share-based compensation 0.0 1.7
Payment of cash dividends (38.3) (40.8)
Net cash provided by financing activities 104.3 185.3
Effect of foreign currency exchange rates on cash and cash equivalents 5.6 (12.1)
Net increase in cash and cash equivalents 225.1 171.2
Cash and cash equivalents at beginning of period 1,420.9 1,639.6
Cash and cash equivalents at end of period $ 1,646.0 $ 1,810.8